Blockade of currents by the antimalarial drug chloroquine in feline ventricular myocytes.
The effects of the antimalarial drug chloroquine on cardiac action potential and membrane currents were studied at clinically relevant concentrations. In cat Purkinje fibers, chloroquine at concentrations of 0.3 to 10 microM increased action potential duration, and reduced maximum upstroke velocity. At concentrations of 3 and 10 microM, chloroquine increased automaticity and reduced maximum diastolic potential, and after 60 min of perfusion with a concentration 10 microM, spontaneous activity was abolished. In isolated cat ventricular myocytes, chloroquine also increased action potential duration in a concentration-dependent manner, and reduced resting membrane potential at 3 and 10 microM. In voltage-clamped cat ventricular myocytes, chloroquine blocked several inward and outward membrane currents. The order of potency was inward rectifying potassium current (I(K1)) > rapid delayed rectifying potassium current (I(Kr)) > sodium current (I(Na)) > L-type calcium current (I(Ca-L)). Only tonic block of I(Na) and I(Ca-L) was observed at a stimulation frequency of 0.1 Hz and no additional blockade was observed during stimulation trains applied at 1 Hz. The effect of chloroquine on I(K1) was voltage-dependent, with less pronounced blockade at negative test potentials. In addition, unblock was achieved by hyperpolarizing pulses to potentials negative to the current reversal potential. Chloroquine blocked the rapid component of the delayed rectifying outward current, I(Kr,) but not the slow component, I(Ks). These findings provide the cellular mechanisms for the prolonged QT interval, impaired ventricular conduction, and increased automaticity induced by chloroquine, which have been suggested as responsible for the proarrhythmic effects of the drug.
Sánchez-Chapula
J A
JA
Unidad "Carlos Méndez" del CUIB, Universidad de Colima, Apdo. Postal 199, C.P. 28000, Colima, México. sancheza@cgic.ucol.mx
Salinas-Stefanon
E
E
Torres-Jácome
J
J
Benavides-Haro
D E
DE
Navarro-Polanco
R A
RA
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D000962:Antimalarials / Q000494:pharmacology*; D020746:Calcium Channels, L-Type / Q000187:drug effects; D002415:Cats; D002738:Chloroquine / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects* / Q000502:physiology; D007473:Ion Channels / Q000187:drug effects*; D015221:Potassium Channels / Q000187:drug effects; D015222:Sodium Channels / Q000187:drug effects
D000962:Antimalarials; D020746:Calcium Channels, L-Type; D007473:Ion Channels; D015221:Potassium Channels; D015222:Sodium Channels; D002738:Chloroquine